Coherus BioSciences Inc (CHRS) — Cash Flow Quality Index
Coherus BioSciences Inc (CHRS) has a Cash Flow Quality Index of -0.08x as of December 2025. Operating cash flow of $-19.72 Million is below net income of $241.20 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore how large is Coherus BioSciences Inc's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Coherus BioSciences Inc Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Coherus BioSciences Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CHRS tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Coherus BioSciences Inc (2019–2025)
Year-by-year earnings quality comparison for Coherus BioSciences Inc. For live market cap and the full company financial profile, see market cap of Coherus BioSciences Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.82x | $-138.51 Million | $168.02 Million | ▼ -15.0% |
| 2024 | -0.72x | $-20.44 Million | $28.51 Million | ▼ -161.5% |
| 2020 | 1.17x | $154.15 Million | $132.24 Million | ▲ +269.3% |
| 2019 | 0.32x | $28.36 Million | $89.83 Million | — |